✦ LIBER ✦

Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis

✍ Scribed by Ashwin N. Ananthakrishnan; Joshua R. Korzenik; Chin Hur

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1668 Mucosal Healing is a Cost-Effecti

✍ Ananthakrishnan, Ashwin N.; Korzenik, Joshua R.; Hur, Chin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Economic impact of combination therapy w

✍ Saito, Shota; Shimizu, Utako; Nan, Zhang; Mandai, Nozomu; Yokoyama, Junji; Teraj 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 674 KB

Infliximab dose escalation vs. initiatio

✍ G. G. KAPLAN; C. HUR; J. KORZENIK; B. E. SANDS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Anti-TNF therapies have eliminated the n

✍ Dr. Anne M. Griffiths 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB